Medical News

RSS

Geron to present updates on product development programs at four investor conferences in September

Geron Corporation today announced that the company will present updates of its product development programs at four investor conferences in the month of September.

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

Holistic health expert highlights the benefits of regular meditatation

Medical costs this year are hitting almost everyone in the pocketbook. With politicians scrambling to come up with a workable solution, Americans face dark days ahead as monthly insurance fees go up again, often with double-digit rate hikes. Is there any hope for hard-working Americans who face the challenge of paying these exorbitant fees?

31 Aug 2009

DYSlipidemia International Study results presented at the ESC congress

According to a new analysis of 22,000 patients, nearly three-quarters of patients taking statins still had at least one lipid abnormality. These results, from a study conducted by Merck & Co., Inc., Whitehouse Station, N.J., U.S.A., which operates in many countries as Merck Sharp & Dohme Limited, were presented today at the European Society of Cardiology (ESC) congress in Barcelona, Spain.

31 Aug 2009

Tianyin Pharmaceutical to discuss its diversified product portfolio at the Rodman & Renshaw Annual Global Investment Conference

Tianyin Pharmaceutical Co. Inc., a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced that it will present at the Rodman & Renshaw Annual Global Investment Conference, to be held September 9-11, 2009, at the New York Palace Hotel in New York City.

31 Aug 2009

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).

31 Aug 2009

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care clinic provider in the U.S., today announced the availability of seasonal flu vaccinations and urged Americans to protect themselves early against the flu. CVS/pharmacy and MinuteClinic are divisions of CVS Caremark (NYSE: CVS), the largest provider of prescriptions in the country.

31 Aug 2009

HOYA Conbio to feature premium dental lasers at LVI Global's first branch in Brisbane

HOYA ConBio, a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI) Global, an internationally renowned provider of post-graduate dental education, to feature premium dental lasers at LVI Global's first branch in Brisbane, Australia. Effective November 1, this new partnership builds on HOYA ConBio's long-standing involvement at LVI Global's headquarters in Las Vegas.

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

First Edition: August 31, 2009

Today's headlines hint that summer's almost over, but the heat will still be on for health reform.

31 Aug 2009

DSG finds place in the Inc. 500 list

The Inc. 500, which ranks the fastest growing U.S. privately held companies, announced that DSG reached No. 82 in the nation, making it the fastest growing privately held company in the Philadelphia area. As an Inc. 500 honoree, DSG shares a prestigious pedigree with such notable companies as Intuit, Microsoft, and Oracle.

31 Aug 2009

Teleflex Medical's OSMO removes water from the expiratory limb of breathing circuit during mechanical ventilation

Teleflex Medical has announced the introduction of OSMO, a universal solution that allows for maintenance free water removal from the expiratory limb of the breathing circuit during mechanical ventilation.

31 Aug 2009

CVS Caremark to provide free seasonal flu shots to unemployed people

As part of a broad-reaching effort to keep Americans healthy this flu season, CVS Caremark today announced its commitment to providing 100,000 free seasonal flu shots to the unemployed. The program will include on-site flu clinics at One-Stop Career Center locations and distribution of vouchers for free flu shots at CVS/pharmacy or MinuteClinic. One-Stop Career Centers offer tools and training to job seekers.

31 Aug 2009

Lidocaine combined with dermal beauty fillers reduces injection discomfort

Beauty injectable fillers such as Restylane(R), Perlane(R) and Juvederm(R) are popular for their ability to restore years of lost facial volume in moments. But for the more sensitive aesthetic patient, the possibility of experiencing injection discomfort or bruising inhibits them from receiving the dramatic visual improvement that could be theirs.

31 Aug 2009

Veeva Systems bags order from three new customers

With the macro U.S. economy starting to show signs of recovery, the life sciences sector is reaching for new remedies to cure its financial ills.

31 Aug 2009

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

31 Aug 2009

Doxorubicin granted orphan drug designation by the FDA

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.

31 Aug 2009

BloodStor biopreservation media product platform for cord blood banking industry

BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced the launch of its BloodStor biopreservation media product platform.

31 Aug 2009

New trial data shows that BIOTRONIK monitoring system is safe and effective for detecting patients' clinical events

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced that new data from the TRUST (Lumos-T Safely Reduces Routine Office Device Follow Up) trial presented at the European Society of Cardiology Congress 2009 demonstrate the benefits of BIOTRONIK Home Monitoring in the early detection of patient clinical events as well as the safe reduction of in-office follow-up visits.

31 Aug 2009

IntelGenx Technologies shareholder conference call to update shareholders on CPI-300

Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. ("IntelGenx") will be holding a shareholder conference call to update shareholders on the company's CPI-300 product and remark on related legal proceedings. The call will be held on Tuesday September 1, 2009 at 2.30 p.m. Eastern Standard Time.

31 Aug 2009

Medical News

Geron to present updates on product development programs at four investor conferences in September

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Holistic health expert highlights the benefits of regular meditatation

DYSlipidemia International Study results presented at the ESC congress

Tianyin Pharmaceutical to discuss its diversified product portfolio at the Rodman & Renshaw Annual Global Investment Conference

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

HOYA Conbio to feature premium dental lasers at LVI Global's first branch in Brisbane

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

First Edition: August 31, 2009

DSG finds place in the Inc. 500 list

Teleflex Medical's OSMO removes water from the expiratory limb of breathing circuit during mechanical ventilation

CVS Caremark to provide free seasonal flu shots to unemployed people

Lidocaine combined with dermal beauty fillers reduces injection discomfort

Veeva Systems bags order from three new customers

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Doxorubicin granted orphan drug designation by the FDA

BloodStor biopreservation media product platform for cord blood banking industry

New trial data shows that BIOTRONIK monitoring system is safe and effective for detecting patients' clinical events

IntelGenx Technologies shareholder conference call to update shareholders on CPI-300

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News